This Post Was Syndicated Under License Via QuoteMedia
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Thursday announced that its wholly-owned subsidiary, ABcann Medicinals Inc., received approval from Health Canada to commence cultivation in the expansion of its Vanluven Road facility in Napanee. The expansion includes production and product development space built to GMP standards and doubles the company’s Ontario cultivation capacity. Cultivation in the expanded area will begin immediately. In addition, the company has incorporated a supercritical CO2 extraction suite for production of concentrates into the facility, which is expected to be brought on-line mid-2019. “The GMP certification ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.